HK2 and glioblastoma: The inhibition of HK2 knockdown not only impeded the tumorigenic growth of glioblastoma, medulloblastoma, and renal cell carcinoma [77–79], but also demonstrated anti-angiogenic effects in pancreatic cancer cells [80].